Intestine and Lower Gastrointestinal Tract ·
Hazard function analysis provided new insights into patient prognosis post colorectal cancer recurrence, revealing a peak risk of death at 2.9 years post-recurrence. Factors like metastatic organs, treatment type, and recurrence interval influenced short-term survival. The method offers an alternative to mean survival time and helps predict mortality risk changes over time.
Journal Article by Ise I, Kawai K (…) Yamaguchi T et 6 al. in Langenbecks Arch Surg
© 2024. The Author(s).
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Intestine and Lower Gastrointestinal Tract
Removing the rectal tumor and liver spread in one operation did not clearly raise complications or hurt survival compared with two separate operations, a French national study found.
Combined and staged surgery had similar complication rates and survival in a French national cohort.
A Japanese randomized trial found that a 14-day schedule of trifluridine-tipiracil plus bevacizumab keeps patients with metastatic colorectal cancer alive as long as the standard 28-day schedule, with far less toxicity.
